Cerebral under investigation for misleading ads, Adderall prescriptions

The Justice Department is investigating behavioral health startup Cerebral over its controlled substances prescriptions, The Verge reported May 9.

The company has paused controlled substances prescriptions for new patients, the report said. The company offers services for anxiety, insomnia, attention deficit hyperactivity disorder and other conditions.

Walmart, CVS and mail-order pharmacy Truepill have stopped filling Cerebral prescriptions for Adderall, a stimulant used to treat ADHD, the report said.

Cerebral has drawn scrutiny for social media ads linking ADHD to obesity. The ads have since been pulled for being misleading, the report said. A former executive is suing the company for allegedly firing him after he raised concerns about Cerebral's stimulant prescribing practices.

"To be clear, at this time, no regulatory or law enforcement authority has accused Cerebral of violating any law," Cerebral said in a statement to Insider. "Cerebral intends to fully cooperate with the investigation, which we already have conveyed to the U.S. Attorney's Office."

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars